Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Cancer
|
Cardiovascular
|
Infection
|
Metabolic
|
Musculoskeletal
|
CNS
|
Respiratory
|
Gastrointestinal
|
Other
|
Therapy Sector Stage - Metabolic
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
Genzyme yet to confirm date of next Fabrazyme shipment
08 September 2011
Austerity takes off gloss from Basilea's Toctino forecasts...
BMS and Sanofi mentioned in $1bn deal speculation over Bioco...
Genzyme shareholders may miss out on first CVR payment
28 July 2011
Market Genzyme plays down latest Cerezyme impurity
26 August 2010
Genzyme enters into pact with Hospira for more manufacturing outsourcing
06 January 2010
Shire submits Replagal for Fabry's disease in the US
23 December 2009
>> More News...
LATEST ANALYSIS
Market Insight - The "ultra-orphan" finds a home at Shire
11 July 2008
>> More Analysis...
LATEST SCIENCE
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism
01 March 2008
Urinary albumin excretion and the renin–angiotensin system in cardiovascular risk management
01 December 2006
An evidence-based systematic review of herb and supplement interactions by the Natural Standard Research Collaboration
01 September 2006
>> More Science...
REFINE BY
COMPANY/ORGANISATION
PFIZER
GLAXOSMITHKLINE
ASTRAZENECA
NOVARTIS
CONDITION
DIABETES
CANCER
OBESITY
PAIN
GEOGRAPHY
JAPAN
INDIA
CHINA
CANADA
DRUG
RIMONABANT
RISPERIDONE
OLANZAPINE
EXENATIDE
